Home › T-Cell Lymphoma › Colorado
T-Cell Lymphoma clinical trials in Colorado
6 studies for T-Cell Lymphoma are looking for participants at sites in Colorado.
Cities in Colorado
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
- Colorado Blood Cancer Institute, Denver
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 16, 2026 · NCT05463263Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Hospital Colorado, Aurora
RecruitingObservational study
Ages 0 to 38 · All sexes · Updated Jun 4, 2026 · NCT06131801A Registry for People With T-cell Lymphoma
- University of Colorado (Data Collection Only), Aurora
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141MB-105 in Patients With CD5 Positive T-cell Lymphoma
- SCRI - Colorado Blood Cancer Institute (CBCI), Denver
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 3, 2025 · NCT06534060Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- University of Colorado Anschutz Medical Campus, Aurora
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2025 · NCT04234048Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital Colorado, Denver
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.